| European Case Law Identifier: | ECLI:EP:BA:2005:T050602.20050118 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 18 January 2005 | ||||||||
| Case number: | T 0506/02 | ||||||||
| Application number: | 95112559.0 | ||||||||
| IPC class: | C12N 15/86 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | cDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses | ||||||||
| Applicant name: | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | ||||||||
| Opponent name: | Akzo Nobel N.V. Conzelmann, Karl-Klaus Prof. Dr. |
||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - novelty (no) First auxiliary request - in breach of Article 123(2) (yes) Second auxiliary request - inventive step (yes), sufficiency (yes) Correction according to Rule 88 EPC (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020506eu1.html
Date retrieved: 17 May 2021